Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Solace Lifesciences
AddedFeb 16, 2024
UpdatedJun 18, 2026
Solace Lifesciences

Solace Lifesciences

Angel

Neuroscience innovator, Solace Lifesciences, offers drug-free solutions to chronic stress via the NuCalm system.

HQ
Wilmington, DE, US
Founded
2002
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to address chronic stress through neuroscience, Solace Lifesciences developed the NuCalm system. The company aims to improve mental health and overall well-being by offering drug-free solutions that leverage patented, clinically proven technology. NuCalm uses four components to biologically mimic the neural pathways that facilitate the body's transition into the first stage of sleep, effectively calming the Hypothalamic-Pituitary-Adrenal Axis and inducing a parasympathetic dominant state within minutes. Their primary market focus includes individuals seeking stress relief, better sleep, and enhanced mental performance.

Solace Lifesciences has garnered attention from notable figures in neuroscience and wellness, as well as investors interested in innovative health technologies. The company has achieved significant milestones, including the successful launch of a mobile app that makes their technology widely accessible. Their impact is evident in the positive testimonials from users who have experienced reduced stress and improved sleep quality. By addressing a critical aspect of mental health without pharmaceuticals, Solace Lifesciences is making a meaningful contribution to the field of neuroscience and personal well-being.

Solace Lifesciences - Quick Facts

When was Solace Lifesciences founded?

Solace Lifesciences was founded in 2002.

Where is Solace Lifesciences' headquarters located?

Solace Lifesciences' headquarters is located in Wilmington, DE, US.

When was Solace Lifesciences' last funding round?

Solace Lifesciences' most recent funding round was for $50k (USD) in September 2010.

How much has Solace Lifesciences raised to-date?

As of Sep 27, 2010, Solace Lifesciences has raised a total of $50k (USD).

How many employees does Solace Lifesciences have?

Solace Lifesciences has 7 employees as of Feb 5, 2024.

Solace Lifesciences - Classification

Ownership
  • Private
Technology
  • Neuroscience
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Stress Management
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified